University of Zurich
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Zurich sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
University of Zurich: 5 sponsored US clinical trials, 1 recruiting.
University of Zurich sponsors 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 3 completed. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Leptomeningeal Cancer, with 1 trials.
Upper-quartile sponsor footprint
University of Zurich sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
5 total, page 1 of 1
Standardized Clinical Assessment of Patients With Leptomeningeal Metastasis
NCT06417710
Multicentric Prospective Validation of the Zurich Pituitary Score
NCT04076046
Therapeutic Antibodies Against Prion Diseases From PRNP Mutation Carriers
NCT02837705
ALLPS VERSUS PVO Randomized Controlled Trial
NCT01775267
Agreement Among Expert Radiologists in Diagnosing Primary Liver Tumors by Magnetic Resonance Imaging (MRI)
NCT01234701
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Therapeutic Areas
What is open in the University of Zurich pipeline
1 recruiting of 5 indexed (20% open); 3 completed (60%).
Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).
Top condition: Leptomeningeal Cancer (1 trial), 4 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Zurich: open-pipeline peers nationwide
Peers matched on 5 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
University of Zurich sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 trials (± recruiting share)
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Align Technology · 20% recruiting · 5 trials
- AltruBio · 20% recruiting · 5 trials
- Alvernia University · 20% recruiting · 5 trials
- Amazentis · 20% recruiting · 5 trials
Related
What to do with this University of Zurich page
5 registered trials is a research-attention snapshot, not an endorsement of University of Zurich or any single study.
- 1 of University of Zurich's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Leptomeningeal Cancer is the condition University of Zurich studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Leptomeningeal Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Zurich pipeline card: 5 registered trials from official public datasets.Report a data error.